MECHANISM OF ACTION
The Wolverine Stack puts BPC-157 and TB-500 together in a single formulation so you get both working at the same time. BPC-157 handles the local work: growing new blood vessels into the injury site, protecting the gut lining, and kicking off repair in tendons and ligaments. TB-500 adds broader coverage: it sends repair signals throughout the body, calls in specialised repair cells, and damps down inflammation system-wide. The idea is that BPC-157's local vascular repair and TB-500's body-wide cell migration create a more complete recovery environment together than either does alone. Available in vial, pen, and nasal spray formats.
RESEARCH APPLICATIONS
- Comprehensive tendon, ligament, and muscle injury recovery
- Post-surgical tissue repair research
- Systemic + local recovery model (TB-500 systemic + BPC-157 local)
- GI repair with systemic anti-inflammatory support
- Athletic recovery and soft tissue research
RESEARCH HIGHLIGHTS
Synergistic Mechanism Evidence
Independent studies on each component show complementary mechanisms - TB-500 mobilises progenitor cells systemically while BPC-157 creates the angiogenic scaffold for integration at the injury site.
Ref: Multiple preclinical studies (see BPC-157 and TB-500 individual pages)
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
-20°C lyophilised. Reconstituted: 2–8°C, 21 days. Same storage rules as component peptides - the blend does not reduce stability.
Regulatory Status
Combined research compound. Same regulatory status as each component. Not WADA listed individually; TB-500 (Tβ4) is WADA S2 prohibited.